DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

PET Imaging Study of Recovered Anorexics

Information source: University of Pittsburgh
Information obtained from ClinicalTrials.gov on August 08, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Anorexia Nervosa

Intervention: Fluoxetine (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: University of Pittsburgh

Official(s) and/or principal investigator(s):
Walter Kaye, M.D., Principal Investigator, Affiliation: UPMC

Overall contact:
Sharon D Barnes, PhD, Phone: 412-647-9964, Email: barnessd@upmc.edu

Summary

Several studies in the past suggest that individuals who have or had anorexia nervosa may have alterations in brain serotonin. Serotonin seems to play an important role in regulating anxiety, mood, and other symptoms found in anorexia nervosa. We will be using a technology called Positron Emission Tomography (PET), which is a method used to take pictures of the body, in this case, the brain. Study participants will undergo two baseline PET scans on the first day of the study. They will then be given a medication called fluoxetine (also know as Prozac) to take for 8 weeks. At the end of the 8th week, they will return for a third PET scan. By comparing the brain scans, before and after fluoxetine treatment, we can understand more about how treatment with fluoxetine affects the serotonin receptors in the brain. We will be comparing brain serotonin system in women who have recovered from anorexia with healthy control women who have never had an eating disorder in order to gain a better understanding of changes in the serotonin system associated with eating disorders. This study may help shed light on how to make fluoxetine a more effective treatment for anorexia nervosa.

Clinical Details

Official title: PET Imaging of Dopaminergic Transmission and Serotonin Markers in Anorexia Nervosa

Study design: Basic Science, Open Label, Parallel Assignment

Primary outcome: serotonin level

Eligibility

Minimum age: 18 Years. Maximum age: 45 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Recovered from Anorexia Nervosa

- Not taking medication for emotional problems

- Regular menstrual cycle

Exclusion Criteria:

- Women who are pregnant or nursing

- Psychoactive medications in the past 30 days

- Neurological disorders.

Locations and Contacts

Sharon D Barnes, PhD, Phone: 412-647-9964, Email: barnessd@upmc.edu

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, United States; Recruiting
Additional Information

Starting date: June 2007
Ending date: June 2017
Last updated: May 21, 2008

Page last updated: August 08, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008